M&A Deal Summary

Exact Sciences Acquires Genomic Health

On July 29, 2019, Exact Sciences acquired life science company Genomic Health for 2.8B USD

Acquisition Highlights
  • This is Exact Sciences’ 2nd transaction in the Life Science sector.
  • This is Exact Sciences’ largest (disclosed) transaction.
  • This is Exact Sciences’ 2nd transaction in the United States.
  • This is Exact Sciences’ 2nd transaction in California.

M&A Deal Summary
Date 2019-07-29
Target Genomic Health
Sector Life Science
Buyer(s) Exact Sciences
Deal Type Add-on Acquisition
Deal Value 2.8B USD
Advisor(s) Goldman Sachs (Financial)
Sullivan & Cromwell
Pillsbury Winthrop Shaw Pittman (Legal)

Target

Genomic Health

Redwood City, California, United States
Genomic Health, Inc. is a life science company, involved in the research and development of genomic based clinical laboratory services for oncology treatment. Genomic Health was founded in 2000 and is based in Redwood City, California.

Search 201,539 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Exact Sciences

Madison, Wisconsin, United States
Category Company
Founded 1995
Sector Life Science
Employees6,500
Revenue 2.5B USD (2023)
DESCRIPTION

Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Exact Sciences was founded in 1995 and is based in Madison, Wisconsin.

DEAL STATS #
Overall 2 of 8
Sector (Life Science) 2 of 6
Type (Add-on Acquisition) 2 of 7
State (California) 2 of 2
Country (United States) 2 of 7
Year (2019) 1 of 1
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-18 Biomatrica

San Diego, California, United States

Biomatrica, Inc. is a provider of sample preservation technology, including blood and saliva sample collection tubes, to the biotech industry. Biomatrica's sample collection tubes, which contain proprietary, sample-stabilizing chemistry, ensure quality preservation of circulating tumor DNA, cells and other biomarkers in biological specimens throughout shipment and storage.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-03 Paradigm Diagnostics

Phoenix, Arizona, United States

Paradigm Diagnostics, Inc. is a medical diagnostics company serving physicians and patients worldwide. The company provides the Paradigm Cancer Diagnostic (PCDx) next-generation sequencing assay to assist physicians and cancer patients to target each patient's specific tumor pathways and genomic changes in their cancer. Through PCDx we assist physicians, patients, and organizations to better understand those fundamental pathways that drive a patient's specific cancer and allow for more effective clinical decision making.

Buy -
Mergr

Product

Company

Legal